Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 5.955
Filtrar
1.
Zhejiang Da Xue Xue Bao Yi Xue Ban ; 49(2): 203-208, 2020 May 25.
Artículo en Chino | MEDLINE | ID: mdl-32391665

RESUMEN

OBJECTIVE: To explore the risk factors of anxiety and depression in patients with suspected coronavirus disease 2019 (COVID-19) so as to achieve early intervention and better clinical prognosis. METHODS: Seventy-six patients with suspected COVID-19 in fever isolation wards of Second Hospital of Lanzhou University were enrolled From January 31, 2020 to February 22, 2020. Their clinical baseline data were collected. The anxiety of patients was assessed by Hamilton Anxiety Scale, and the depression of patients was assessed by Hamilton Depression Scale. Multivariate Logistic regression analysis was performed to explore the risk factors of anxiety and depression in these patients. RESULTS: Female patients are more likely to have anxiety (OR=3.206, 95%CI: 1.073-9.583, P<0.05) and depression (OR=9.111, 95%CI: 2.143-38.729, P<0.01) than male patients; patients with known contact history of epidemic area and personnel in epidemic area are more likely to have depression (OR=3.267, 95%CI: 1.082-9.597, P<0.05). CONCLUSIONS: During the isolation treatment of suspected COVID-19 patients, early psychological intervention should be carried out for the female patients with known contact history of epidemic area and personnel in epidemic area, and drug treatment should be given in advance if necessary.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus , Depresión , Pandemias , Neumonía Viral , Ansiedad/diagnóstico , Ansiedad/etiología , Ansiedad/terapia , Betacoronavirus/aislamiento & purificación , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/psicología , Depresión/diagnóstico , Depresión/etiología , Femenino , Humanos , Modelos Logísticos , Masculino , Neumonía Viral/complicaciones , Neumonía Viral/diagnóstico , Neumonía Viral/psicología , Factores de Riesgo
2.
Complement Ther Clin Pract ; 39: 101166, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32379637

RESUMEN

BACKGROUND: Different degrees of disorders are reported in respiratory function, physical function and psychological function in patients with corona virus disease 2019 (COVID-19), especially in elderly patients. With the experience of improved and discharged COVID-19 patients, timely respiratory rehabilitation intervention may improve prognosis, maximize functional preservation and improve quality of life (QoL), but there lacks of studies worldwide exploring the outcome of this intervention. OBJECTIVE: To investigate the effects of 6-week respiratory rehabilitation training on respiratory function, QoL, mobility and psychological function in elderly patients with COVID-19. METHODS: This paper reported the findings of an observational, prospective, quasi-experimental study, which totally recruited 72 participants, of which 36 patients underwent respiratory rehabilitation and the rest without any rehabilitation intervention. The following outcomes were measured: pulmonary function tests including plethysmography and diffusing lung capacity for carbon monoxide (DLCO), functional tests (6-min walk distance test), Quality of life (QoL) assessments (SF-36 scores), activities of daily living (Functional Independence Measure, FIM scores), and mental status tests (SAS anxiety and SDS depression scores). RESULTS: After 6 weeks of respiratory rehabilitation in the intervention group, there disclosed significant differences in FEV1(L), FVC(L), FEV1/FVC%, DLCO% and 6-min walk test. The SF-36 scores, in 8 dimensions, were statistically significant within the intervention group and between the two groups. SAS and SDS scores in the intervention group decreased after the intervention, but only anxiety had significant statistical significance within and between the two groups. CONCLUSIONS: Six-week respiratory rehabilitation can improve respiratory function, QoL and anxiety of elderly patients with COVID-19, but it has little significant improvement on depression in the elderly.


Asunto(s)
Infecciones por Coronavirus/rehabilitación , Neumonía Viral/rehabilitación , Terapia Respiratoria , Actividades Cotidianas , Anciano , Ansiedad/etiología , Ansiedad/terapia , Betacoronavirus , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/psicología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Pandemias , Neumonía Viral/complicaciones , Neumonía Viral/psicología , Estudios Prospectivos , Calidad de Vida , Pruebas de Función Respiratoria , Terapia Respiratoria/métodos , Caminata
3.
Complement Ther Clin Pract ; 39: 101132, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32379667

RESUMEN

BACKGROUND: Patients with Coronavirus Disease 2019(COVID-19) will experience high levels of anxiety and low sleep quality due to isolation treatment. Some sleep-improving drugs may inhibit the respiratory system and worsen the condition. Prolonged bedside instruction may increase the risk of medical infections. OBJECTIVE: To investigate the effect of progressive muscle relaxation on anxiety and sleep quality of COVID-19. METHODS: In this randomized controlled clinical trial, a total of 51 patients who entered the isolation ward were included in the study and randomly divided into experimental and control groups. The experimental group used progressive muscle relaxation (PMR) technology for 30 min per day for 5 consecutive days. During this period, the control group received only routine care and treatment. Before and after the intervention, the Spielberger State-Trait Anxiety Scale (STAI) and Sleep State Self-Rating Scale (SRSS) were used to measure and record patient anxiety and sleep quality. Finally, data analysis was performed using SPSS 25.0 software. RESULTS: The average anxiety score (STAI) before intervention was not statistically significant (P = 0.730), and the average anxiety score after intervention was statistically significant (P < 0.001). The average sleep quality score (SRSS) of the two groups before intervention was not statistically significant (P = 0.838), and it was statistically significant after intervention (P < 0.001). CONCLUSION: Progressive muscle relaxation as an auxiliary method can reduce anxiety and improve sleep quality in patients with COVID-19.


Asunto(s)
Ansiedad , Infecciones por Coronavirus , Pandemias , Neumonía Viral , Terapia por Relajación , Trastornos del Sueño-Vigilia , Adulto , Ansiedad/terapia , Trastornos de Ansiedad , Entrenamiento Autogénico , Betacoronavirus , Infecciones por Coronavirus/complicaciones , Infecciones por Coronavirus/psicología , Femenino , Humanos , Masculino , Relajación Muscular , Neumonía Viral/complicaciones , Neumonía Viral/psicología , Terapia por Relajación/métodos , Sueño/fisiología , Trastornos del Sueño-Vigilia/etiología , Trastornos del Sueño-Vigilia/terapia
4.
Trials ; 21(1): 402, 2020 May 13.
Artículo en Inglés | MEDLINE | ID: mdl-32404126

RESUMEN

OBJECTIVES: This study aims to assess the effectiveness of delivering Solution Focused Brief Therapy (SFBT) through telecommunication with a group of adolescents who present anxiety symptoms during the COVID-19 outbreak. We hypothesize that participants who are randomly assigned to receive 2-4 sessions of Solution Focused Brief Therapy would have better clinical outcomes than participants who are in the waitlist group. We additionally hypothesized that using SFBT can also change participants' depression levels and their coping strategies in dealing with distress during the COVID-19 pandemic. TRIAL DESIGN: This study employs a randomized delayed crossover open label controlled trial in adolescents who are presenting anxiety symptoms during the COVID-19 outbreak. Participants who meet the enrollment criteria stated below will be invited to participate in this study through telecommunication. Those accepting will be randomly allocated to the intervention group or waitlist group.


Asunto(s)
Ansiedad/terapia , Betacoronavirus , Infecciones por Coronavirus/psicología , Neumonía Viral/psicología , Psicoterapia Breve , Ensayos Clínicos Controlados Aleatorios como Asunto , Adolescente , Infecciones por Coronavirus/diagnóstico , Infecciones por Coronavirus/epidemiología , Femenino , Humanos , Masculino , Pandemias , Neumonía Viral/diagnóstico , Neumonía Viral/epidemiología , Telemedicina
5.
J Zhejiang Univ Sci B ; 21(5): 394-399, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32425005

RESUMEN

At the end of 2019, a new form of pneumonia disease known as the corona virus disease 2019 (COVID-19) rapidly spread throughout most provinces of China, and the total global number of COVID-19 cases has surpassed 500 000 by Mar. 27, 2020 (WHO, 2020). On Jan. 30, 2020, the World Health Organization (WHO) declared COVID-19 a global health emergency (WHO, 2020). COVID-19 causes most damage to the respiratory system, leading to pneumonia or breathing difficulties. The confirmed case fatality risk (cCFR) was estimated to be 5% to 8% (Jung et al., 2020). Besides physical pain, COVID-19 also induces psychological distress, with depression, anxiety, and stress affecting the general population, quarantined population, medical staff, and patients at different levels (Kang et al., 2020; Xiang et al., 2020). Previous research on patients in isolation wards highlighted the risk of depressed mood, fear, loneliness, frustration, excessive worries, and insomnia (Abad et al., 2010).


Asunto(s)
Infecciones por Coronavirus/psicología , Infecciones por Coronavirus/terapia , Terapia Conductual Dialéctica , Neumonía Viral/psicología , Neumonía Viral/terapia , Adulto , Ansiedad/terapia , Betacoronavirus , China , Depresión/terapia , Femenino , Humanos , Pandemias , Periodo Posparto , Embarazo , Mujeres Embarazadas/psicología
6.
J Zhejiang Univ Sci B ; 21(5): 400-404, 2020 May.
Artículo en Inglés | MEDLINE | ID: mdl-32425006

RESUMEN

Public health crises, such as the outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) since Dec. 2019, are widely acknowledged as severe traumatic events that impose threats not only because of physical concerns but also because of the psychological distress of infected patients. We designed an internet-based integrated intervention and evaluated its efficacy on depression and anxiety symptoms in patients infected by SARS-CoV-2.


Asunto(s)
Ansiedad/terapia , Infecciones por Coronavirus/psicología , Depresión/terapia , Internet , Neumonía Viral/psicología , Autocuidado/métodos , Adulto , Betacoronavirus , Teléfono Celular , China , Femenino , Humanos , Masculino , Persona de Mediana Edad , Atención Plena , Pandemias , Estudios Prospectivos , Distrés Psicológico , Terapia por Relajación
7.
Psychiatr Danub ; 32(1): 115-121, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32303041

RESUMEN

BACKGROUND: Group interventions can have negative effects for patients with anxiety disorders. Stimuli which provoke side effects may be the group setting, the content, or the interaction between the participants in the group. This study is the first to report negative effects from a cognitive behavioral group intervention, in comparison with an unspecific, recreational group for anxiety patients. SUBJECTS AND METHODS: 107 patients with work-related anxiety disorders were randomized to either a cognitive behavioral group therapy (work-coping group WG) or an unspecific group encounter aimed at increasing recreational activities (recreational group RG). Patients completed the Unwanted Events in Group Therapy Scale (UE-G scale). RESULTS: In the work-coping group, 41.9% of the patients reported at least one relevant side effect, as compared to 28.9% in the recreational group. These included an increase in the perception of anxiety and work-problems, feelings of exposure to criticism and the development of negative views on group therapy as such. CONCLUSIONS: This is the first randomized, controlled, therapy study in anxiety patients to systematically investigate side effects. Work-coping group interventions have, despite their useful main effects, specific negative effects, when compared with group encounters. Group psychotherapists or group moderators should be aware of the potential side effects in anxiety patients.


Asunto(s)
Trastornos de Ansiedad/psicología , Trastornos de Ansiedad/terapia , Terapia Cognitivo-Conductual , Psicoterapia de Grupo , Recreación/psicología , Adaptación Psicológica , Ansiedad/psicología , Ansiedad/terapia , Femenino , Humanos , Masculino , Persona de Mediana Edad
9.
Medicina (B Aires) ; 80 Suppl 2: 47-52, 2020.
Artículo en Español | MEDLINE | ID: mdl-32150713

RESUMEN

This article is intended to review the effect of mindfulness-based interventions on perinatal mental health. A search of the literature published until September 2019 in the Web of Science (WOS) database was carried out. Taking into account the inclusion and exclusion criteria and after reading the title and abstracts of the articles found, 26 of them have been selected. Finally we only analyzed randomized controlled trials (RCTs) that show data on anxiety, depression, perceived stress and mindfulness before and after intervention and with follow-up data. The results found show that mindfulness-based interventions (IBMs) are more effective than the usual healthcare (TAU) that pregnant women receive for the reduction of depressive, anxious and perceived stress symptoms as well as increasing their postintervention mindfulness levels. For future research, a postpartum follow-up would be considered interesting taking into account variables such as the quality of the mother-baby attachment, adherence to breastfeeding and the evolutionary development of the newborn.


Asunto(s)
Ansiedad/terapia , Depresión/terapia , Atención Plena/métodos , Mujeres Embarazadas/psicología , Ansiedad/psicología , Depresión/psicología , Depresión Posparto/psicología , Depresión Posparto/terapia , Femenino , Humanos , Atención Perinatal/métodos , Embarazo , Complicaciones del Embarazo/psicología , Complicaciones del Embarazo/terapia , Resultado del Tratamiento
10.
Magy Onkol ; 64(1): 62-69, 2020 Mar 17.
Artículo en Húngaro | MEDLINE | ID: mdl-32181764

RESUMEN

Cancer is a huge psychological difficulty both for the patient and the caregivers. Patients often suffer from hopelessness, helplessness, depression, anxiety or other psychological disturbances. Although the cognitive behavioral interventions (cognitive behavioral therapy, mindfulness) are evidence based, short, time-limited, focused treatments for patients with cancer, in Hungary there are only little evidence and experiences about application of cognitive behavioral methods in the oncological care. The main goal of this review to provide a survey about the cognitive behavioral theories and the international practical experiences in the field of oncological care, furthermore, to propose to apply these structured, directive, problem-focused interventions among patients with cancer to professionals which are able to decrease distress of patients or caregivers and these methods are able to treat the mental disorders, such as anxiety, depression, PTSD, which usually relate with cancer.


Asunto(s)
Ansiedad/terapia , Terapia Cognitivo-Conductual , Depresión/terapia , Neoplasias/complicaciones , Neoplasias/psicología , Trastornos por Estrés Postraumático/terapia , Ansiedad/etiología , Depresión/etiología , Humanos , Hungría , Trastornos por Estrés Postraumático/etiología
11.
BMC Health Serv Res ; 20(1): 85, 2020 Feb 04.
Artículo en Inglés | MEDLINE | ID: mdl-32019521

RESUMEN

BACKGROUND: Anxiety and depression are associated with substantial functional impairment. Prompt Mental Health Care (PMHC), the Norwegian adaptation of IAPT is currently piloted across Norway, as a means to improve access to evidence-based care for adults with anxiety disorders (including subthreshold cases) and minor to moderate depression. The aims of the current paper were to examine the change in work status and functional status from pre- to post-treatment and 12 months post-treatment among clients at the first 12 PMHC pilot sites, and whether degree of change differed across sociodemographic characteristics. METHODS: A prospective cohort design was used, including working age clients receiving treatment between October 2014 and December 2016 (n = 1446, participation rate = 61%). Work status and functional status were self-reported, the latter by the Work and Social Adjustment Scale (WSAS). Changes in work status and WSAS score were examined through multilevel models based on maximum likelihood estimation. Likelihood ratio tests were performed to determine whether the interaction between time and the respective background variables were statistically significant. RESULTS: A substantial increase in regular work participation was observed from pre- to post-treatment, which further had increased at 12 months post-treatment. The increase was driven by a corresponding reduction in proportion of clients working and receiving benefits (OR 0.38 [0.29-0.50] baseline to final treatment, OR = 0.19 [0.12-0.32] final treatment to 12-months post-treatment), while no statistically significant change was observed in proportion out of work. Large improvement (ES = - 0.89) in WSAS score was observed from pre- to post treatment. WSAS score at 12 months post-treatment remained at the post-treatment level. CONCLUSIONS: Previous research has shown substantial symptom improvement among clients receiving treatment in PMHC. The current findings indicate that PMHC might also be able to aid adults struggling with mild to moderate anxiety and depression in returning to usual level of functioning. The degree to which the observed improvements are attributable to the treatment need nonetheless to be confirmed in a trial including a control group and with more complete follow-up data from registries.


Asunto(s)
Ansiedad/terapia , Depresión/terapia , Rendimiento Físico Funcional , Trabajo/estadística & datos numéricos , Adolescente , Adulto , Anciano , Ansiedad/psicología , Depresión/psicología , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Noruega , Estudios Prospectivos , Factores Socioeconómicos , Resultado del Tratamiento , Adulto Joven
12.
Adv Exp Med Biol ; 1191: 219-235, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32002932

RESUMEN

Although anxiety and depression have been considered as two distinct entities according to the diagnostic criteria, anxious depression (comorbid anxiety and depression) is relatively a common syndrome. According to the DSM-5 criteria, it uses "with anxious distress specifier" to define anxious depression in its MDD section. Anxious depression is known to have different neurobiological profiles compared to non-anxious depression. Several studies have revealed significant differences between anxious depression and non-anxious depression regarding the hypothalamic-pituitary-adrenal (HPA) axis function, structural and functional brain imaging findings, inflammation markers, etc. Patients with anxious depression were significantly more likely to be found in primary care setting and more likely to be associated with female gender, non-single, unemployed, less educated, and more severe depression. Previous reports also showed that patients with anxious depression had more frequent episodes of major depression and a higher risk of suicidal ideation and previous suicide attempts than those with non-anxious depression. Although anxious depression is known to be associated with poor treatment outcomes in several studies, recent researches have sought to find better treatment strategy to improve patients with anxious depression.


Asunto(s)
Trastornos de Ansiedad/complicaciones , Trastornos de Ansiedad/terapia , Trastorno Depresivo Mayor/complicaciones , Trastorno Depresivo Mayor/terapia , Ansiedad/complicaciones , Ansiedad/diagnóstico , Ansiedad/terapia , Trastornos de Ansiedad/diagnóstico , Comorbilidad , Depresión/complicaciones , Depresión/diagnóstico , Depresión/terapia , Trastorno Depresivo Mayor/diagnóstico , Humanos
13.
Adv Exp Med Biol ; 1191: 451-464, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32002941

RESUMEN

Psychodynamic theory is founded on the idea that much, if not most, of human behavior is influenced by forces and experiences that lie outside of conscious awareness. It posits that despite what we may or may not recognize about our lived experience, an essential connection exists between unconscious processes and everyday psychological functioning. By extension, psychodynamic theory presumes that unconscious conflicts are pathognomonic of anxiety disorders and anxiety symptoms more generally. At the same time, the term "psychodynamic" refers not only to that which occurs within one's mind but also what happens between people and within families, groups, and systems. A comprehensive psychodynamic treatment of anxiety attempts to take into account these multiple domains of experience and functioning (including biological and genetic considerations) and applies a specific therapeutic approach to working with patients based in part on clinical techniques first developed by Sigmund Freud 100 years ago.


Asunto(s)
Trastornos de Ansiedad/psicología , Trastornos de Ansiedad/terapia , Ansiedad/psicología , Ansiedad/terapia , Psicoterapia Psicodinámica , Concienciación , Humanos
14.
Adv Exp Med Biol ; 1191: 561-576, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32002946

RESUMEN

Recent data has linked anxiety and its disorders in late life to increased morbidity and mortality, especially related to a higher cardiovascular burden and an increased cognitive decline. Clinically, anxiety symptoms may be more difficult to elicit in older adults who are less accurate in identifying anxiety symptoms and tend to minimize symptoms and to attribute symptoms to physical illness. Although SSRIs have proven more effective than psychotherapy in late-life anxiety, many elderly anxious subjects prefer psychotherapeutic interventions. These interventions appear to work best when tailored for the needs, expectations, and cultural background of older anxious subjects.


Asunto(s)
Trastornos de Ansiedad , Anciano , Ansiolíticos/uso terapéutico , Ansiedad/complicaciones , Ansiedad/diagnóstico , Ansiedad/psicología , Ansiedad/terapia , Trastornos de Ansiedad/complicaciones , Trastornos de Ansiedad/diagnóstico , Trastornos de Ansiedad/psicología , Trastornos de Ansiedad/terapia , Enfermedades Cardiovasculares/complicaciones , Comorbilidad , Humanos , Psicoterapia , Inhibidores de la Captación de Serotonina/uso terapéutico
15.
Adv Exp Med Biol ; 1191: 523-541, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32002944

RESUMEN

Exposure therapy, a key treatment for anxiety disorders, can be modelled in the laboratory using Pavlovian fear extinction. Understanding the hormonal and neurobiological mechanisms underlying fear extinction in females, who are twice more likely than males to present with anxiety disorders, may aid in optimising exposure therapy outcomes in this population. This chapter will begin by discussing the role of the sex hormones, estradiol and progesterone, in fear extinction in females. We will also propose potential mechanisms by which these hormones may modulate fear extinction. The second half of this chapter will discuss the long-term hormonal, neurological and behavioural changes that arise from pregnancy and motherhood and how these changes may alter the features of fear extinction in females. Finally, we will discuss implications of this research for the treatment of anxiety disorders in women with and without prior reproductive experience.


Asunto(s)
Trastornos de Ansiedad/metabolismo , Trastornos de Ansiedad/terapia , Ansiedad/metabolismo , Ansiedad/terapia , Estradiol/metabolismo , Progesterona/metabolismo , Reproducción , Ansiedad/psicología , Trastornos de Ansiedad/psicología , Extinción Psicológica , Miedo , Femenino , Humanos , Embarazo
17.
Acad Emerg Med ; 27(2): 92-99, 2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31957143

RESUMEN

BACKGROUND: Anxiety and acute distress are significant concerns in the emergency department (ED). Adult coloring books are often utilized as an effective means of relaxation in waiting rooms and newsstands, but there are no reported randomized trials examining their effectiveness as a treatment for anxiety. METHODS: We set out to examine the effectiveness of adult coloring books using a randomized placebo-controlled trial at a university-affiliated tertiary ED. Anxiety was measured using a validated self-reporting score, the Hospital Anxiety and Depression Scale (HADS-A), with a range of 0 to 21. Patients with HADS-A ≥ 7 were randomly assigned to either an adult coloring pack (n = 26) or placebo pack (n = 27). The primary outcome measure was the within-patient change in HADS-A scores following 2 hours of exposure. RESULTS: A convenience sample of 117 patients were screened, and 53 patients were randomized. Characteristics of allocated groups were similar in terms of sex, diagnosis, and ethnicity. A higher proportion of intervention subjects spent ≥1 hour engaged with their activity (46.2% vs. 4.0%, p = 0.01). For the primary outcome measure, the mean within-patient decrease in HADS-A score at 2 hours for intervention subjects was 3.7 (95% confidence interval [CI] = 2.4 to 5.1, p < 0.001) versus a decrease of 0.3 (95% CI = -0.6 to 1.2, p = 0.51) in the placebo group. CONCLUSIONS: Among ED patients, exposure to adult coloring books resulted in lower self-reported levels of anxiety at 2 hours compared to placebo.


Asunto(s)
Ansiedad/terapia , Terapia con Arte/métodos , Adulto , Ansiedad/psicología , Servicio de Urgencia en Hospital/organización & administración , Femenino , Humanos , Masculino , Persona de Mediana Edad , Autoinforme , Factores de Tiempo
18.
Pediatrics ; 145(2)2020 02.
Artículo en Inglés | MEDLINE | ID: mdl-31964760

RESUMEN

Pediatricians regularly care for children who have experienced child maltreatment. Child maltreatment is a risk factor for a broad range of mental health problems. Issues specific to child maltreatment make addressing emotional and behavioral challenges among maltreated children difficult. This clinical report focuses on 2 key issues necessary for the care of maltreated children and adolescents in pediatric settings: trauma-informed assessments and the role of pharmacotherapy in maltreated children and adolescents. Specific to assessment, current or past involvement of the child in the child welfare system can hinder obtaining necessary information or access to appropriate treatments. Furthermore, trauma-informed assessments can help identify the need for specific interventions. Finally, it is important to take both child welfare system and trauma-informed assessment approaches into account when considering the use of psychotropic agents because there are critical diagnostic and systemic issues that affect the prescribing and discontinuing of psychiatric medications among children with a history of child maltreatment.


Asunto(s)
Maltrato a los Niños/psicología , Servicios de Protección Infantil , Trastornos Mentales/tratamiento farmacológico , Psicotrópicos/uso terapéutico , Adolescente , Ansiedad/etiología , Ansiedad/terapia , Trastorno por Déficit de Atención con Hiperactividad/diagnóstico , Trastorno por Déficit de Atención con Hiperactividad/etiología , Trastorno por Déficit de Atención con Hiperactividad/terapia , Niño , Maltrato a los Niños/diagnóstico , Maltrato a los Niños/legislación & jurisprudencia , Servicios de Protección Infantil/legislación & jurisprudencia , Bases de Datos Factuales , Depresión/etiología , Depresión/terapia , Exposición a la Violencia/psicología , Encuestas Epidemiológicas , Humanos , Trastornos Mentales/diagnóstico , Trastornos Mentales/etiología , Pediatras , Resiliencia Psicológica , Trastornos del Sueño-Vigilia/etiología , Determinantes Sociales de la Salud , Trastornos por Estrés Postraumático/diagnóstico , Trastornos por Estrés Postraumático/etiología , Trastornos por Estrés Postraumático/terapia , Privación de Tratamiento
20.
Z Kinder Jugendpsychiatr Psychother ; 48(1): 33-46, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30422059

RESUMEN

This meta-review integrates the current meta-analysis literature on the efficacy of internet- and mobile-based interventions (IMIs) for mental disorders and somatic diseases in children and adolescents. Further, it summarizes the moderators of treatment effects in this age group. Using a systematic literature search of PsycINFO and MEDLINE/PubMed, we identified eight meta-analyses (N = 8,417) that met all inclusion criteria. Current meta-analytical evidence of IMIs exists for depression (range of standardized mean differences, SMDs = .16 to .76; 95 % CI: -.12 to 1.12; k = 3 meta-analyses), anxiety (SMDs = .30 to 1.4; 95 % CI: -.53 to 2.44; k = 5) and chronic pain (SMD = .41; 95 % CI: .07 to .74; k = 1) with predominantly nonactive control conditions (waiting-list; placebo). The effect size for IMIs across mental disorders reported in one meta-analysis is SMD = 1.27 (95 % CI: .96 to 1.59; k = 1), the effect size of IMIs for different somatic conditions is SMD = .49 (95 % CI: .33 to .64; k = 1). Moderators of treatment effects are age (k = 3), symptom severity (k = 1), and source of outcome assessment (k = 1). Quality ratings with the AMSTAR-2-checklist indicate acceptable methodological rigor of meta-analyses included. Taken together, this meta-review suggests that IMIs are efficacious in some health conditions in youths, with evidence existing primarily for depression and anxiety so far. The findings point to the potential of IMIs to augment evidence based mental healthcare for children and adolescents.


Asunto(s)
Trastornos de Ansiedad/terapia , Teléfono Celular , Trastorno Depresivo/terapia , Internet , Adolescente , Ansiedad/terapia , Niño , Depresión/terapia , Humanos , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA